ArticlePediatric transplantation2026

Subcutaneous Alemtuzumab as Salvage Therapy for Acute Kidney Transplant Rejection Following Thymoglobulin Anaphylaxis: A Pediatric Case Report.

Kevin W O'Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.